Literature DB >> 871704

The natural history of chronic airflow obstruction.

C Fletcher, R Peto.   

Abstract

A prospective epidemiological study of the early stages of the development of chronic obstructive pulmonary disease was performed on London working men. The findings showed that forced expiratory volume in one second (FEV1) falls gradually over a lifetime, but in most non-smokers and many smokers clinically significant airflow obstruction never develops. In susceptible people, however, smoking causes irreversible obstructive changes. If a susceptible smoker stops smoking he will not recover his lung function, but the average further rates of loss of FEV1 will revert to normal. Therefore, severe or fatal obstructive lung disease could be prevented by screening smokers' lung function in early middle age if those with reduced function could be induced to stop smoking. Infective processes and chronic mucus hypersecretion do not cause chronic airflow obstruction to progress more rapidly. There are thus two largely unrelated disease processes, chronic airflow obstruction and the hypersecretory disorder (including infective processes).

Entities:  

Mesh:

Year:  1977        PMID: 871704      PMCID: PMC1607732          DOI: 10.1136/bmj.1.6077.1645

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  13 in total

1.  AMERICAN EMPHYSEMA AND BRITISH BRONCHITIS. A STANDARDIZED COMPARATIVE STUDY.

Authors:  C M FLETCHER; N L JONES; B BURROWS; A H NIDEN
Journal:  Am Rev Respir Dis       Date:  1964-07

2.  Respiratory symptoms, bronchitis, and ventilatory capacity in men. An Anglo-Danish comparison, with special reference to differences in smoking habits.

Authors:  H C OLSEN; J C GILSON
Journal:  Br Med J       Date:  1960-02-13

3.  The histology of generalized pulmonary emphysema. I. The genesis of the early centrolobular lesion: focal emphysema.

Authors:  K H MCLEAN
Journal:  Australas Ann Med       Date:  1957-05

4.  Clinical pattern of chronic bronchitis.

Authors:  N C OSWALD; J T HAROLD; W J MARTIN
Journal:  Lancet       Date:  1953-09-26       Impact factor: 79.321

5.  Evolution of the ventilatory capacity in chronic bronchitis.

Authors:  P Howard
Journal:  Br Med J       Date:  1967-08-12

6.  The causes of death in chronic airway obstruction. I. The unreliability of death certificates and routine autopsies.

Authors:  R S Mitchell; S H Walker; G W Silvers; G Dart; J C Maisel
Journal:  Am Rev Respir Dis       Date:  1968-10

7.  Cigarette smoking and changes in respiratory findings.

Authors:  G W Comstock; W J Brownlow; R W Stone; P E Sartwell
Journal:  Arch Environ Health       Date:  1970-07

8.  The predictive value of a postal questionnaire on cardio-respiratory symptoms.

Authors:  D E Krueger; E Rogot; W C Blackwelder; D D Reid
Journal:  J Chronic Dis       Date:  1970-11

9.  Course and prognosis of chronic obstructive lung disease. A prospective study of 200 patients.

Authors:  B Burrows; R H Earle
Journal:  N Engl J Med       Date:  1969-02-20       Impact factor: 91.245

10.  Serial studies of 100 patients with chronic airway obstruction in London and Chicago.

Authors:  N L Jones; B Burrows; C M Fletcher
Journal:  Thorax       Date:  1967-07       Impact factor: 9.139

View more
  558 in total

Review 1.  Home treatment of COPD exacerbations.

Authors:  D S Postma; N H Ten Hacken; H A Kerstjens; G H Koëter
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

2.  Smoking cessation, decline in pulmonary function and total mortality: a 30 year follow up study among the Finnish cohorts of the Seven Countries Study.

Authors:  M Pelkonen; I L Notkola; H Tukiainen; M Tervahauta; J Tuomilehto; A Nissinen
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

3.  Preventing exacerbations of chronic bronchitis and COPD.

Authors:  A Ekberg-Jansson; S Larsson; C G Löfdahl
Journal:  BMJ       Date:  2001-05-26

Review 4.  Chronic airway disease: the infection connection.

Authors:  S B Greenberg; R L Atmar
Journal:  Trans Am Clin Climatol Assoc       Date:  1999

5.  Enhanced neutrophil response in chronic obstructive pulmonary disease.

Authors:  A Noguera; S Batle; C Miralles; J Iglesias; X Busquets; W MacNee; A G Agustí
Journal:  Thorax       Date:  2001-06       Impact factor: 9.139

6.  IgG subclasses in smokers with chronic bronchitis and recurrent exacerbations.

Authors:  I Qvarfordt; G C Riise; B A Andersson; S Larsson
Journal:  Thorax       Date:  2001-06       Impact factor: 9.139

Review 7.  Management of an acute exacerbation of copd: are we ignoring the evidence?

Authors:  M K Johnson; R D Stevenson
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

8.  Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study.

Authors:  Debra A Stern; Wayne J Morgan; Anne L Wright; Stefano Guerra; Fernando D Martinez
Journal:  Lancet       Date:  2007-09-01       Impact factor: 79.321

Review 9.  Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective.

Authors:  K Suresh Babu; Jack A Kastelik; Jaymin B Morjaria
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

10.  Lung Function Trajectories Leading to Chronic Obstructive Pulmonary Disease as Predictors of Exacerbations and Mortality.

Authors:  Jacob Louis Marott; Truls Sylvan Ingebrigtsen; Yunus Çolak; Jørgen Vestbo; Peter Lange
Journal:  Am J Respir Crit Care Med       Date:  2020-07-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.